The slip
PARKINSON RECEIPTno. 15355
30 Oct 2026, 17:47 UTCdopamine neurons, braak
predictionST6GALNAC4 in dopamine neurons tracks Braak Lewy-body stage
registereddc68927046ae252f
discovery-0.30 p=0.441 n=9
replication-0.34 p=0.374 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.30, p 0.441)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT684484411905ce5f0fa04469…
follows 636ac7f2d891…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15355: ST6GALNAC4 in dopamine neurons, braak
- power
- full sample -0.30 (p 0.228, n 18), 95% CI -0.67 to +0.20. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.28 (p 0.254, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.30 (p 0.232, n 18). could be the mix.
- skeptic
- leave-one-out range -0.37 to -0.20, sign flips 0; without severely affected donors -0.30 (p 0.228, n 18). fragile.
- cell type
- strongest in astrocytes: -0.68 (p 0.0019, n 18) vs -0.30 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ST6GALNAC4 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ST6GALNAC4 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.50 p 0.076 (needs p < 1.5e-4)